Novel drugs to drive HIV into remission [ 2016 - ]

Research Grant

Researchers: Prof Damian Purcell (Principal investigator) ,  Dr Brad Sleebs ,  Prof Sharon Lewin

Brief description Even in well-resourced countries, the ability to continue treating HIV patients for their lifetime may become unaffordable, which has focused attention on developing a cure for HIV. We have exploited unique insights into a pathway for Tat expression from latent HIV to identify novel compounds that target HIV latency. This project assembles a multidisciplinary team to optimize the lead compounds, and develop novel drug regimens to fast-track into clinical development as a HIV-curative therapy.

Funding Amount $1,001,192.00

Funding Scheme Development Grants

Notes Development Grant